medigraphic.com
ISSN 2221-2434 (Electronic)

2022, Number 2

<< Back Next >>

Finlay 2022; 12 (2)

Marchiafava-bignami disease: a reality. A case report

Valladares VM, García LJI, Sánchez LA

Language: Spanish
References: 10
Page: 239-244
PDF size: 299.52 Kb.


ABSTRACT

Marchiafava-Bignami disease has been recognized as a syndrome characterized by necrosis and focal demyelination of the corpus callosum. It was first described in 1903 by the pathologists Marchiafava and Bignami in three Italian alcoholic patients who drink red wine. The case of a 55-year-old patient is reported, alcoholic, who attended with generalized epileptic seizures and impaired level of consciousness. Magnetic resonance imaging of the skull revealed demyelination of the corpus callosum, white and gray matter of the parietal and frontal lobes, leading to the diagnosis of acute Marchiafava-Bignami type A disease. The patient died of hospital-acquired pneumonia 15 days later of income. Knowledge of this disease is necessary, because despite the poor prognosis of its acute form, cases of good evolution with timely diagnosis and treatment are reported. The case is presented with the aim of evidencing the diagnosis of a rare disease that can be expressed in a variable way and qualifies as a medical emergency.


REFERENCES

  1. Reyes G, Mendizábal R, Acosta R, Ayala A, Espinosa IF, Delgado C, et al. Enfermedad de Marchiafava-Bignami. Arch Neurocien Mex[Internet]. 2008[citado 12 Feb 2021];13(2):[aprox. 5p.]. Disponible en: https://www.medigraphic.com/pdfs/arcneu/ane-2008/ane082k.pdf.1.

  2. Franco C, De Lipsis L, Belmonte R, Cerase A. Reversible MR Findings in Marchiafava-Bignami Disease. Case Rep Neurol Med. 2019;195(10):25-30.

  3. Rodríguez S, Bravo J, Ramos LA, Martín C, Ortiz R, Puente T. Enfermedad de Marchiafava-Bignami en Cuidados Intensivos. Med Intensiva[Internet]. 2005[citado 18 Jun 2020];29(7):[aprox. 4p.]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S02105691057426983. .

  4. Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry. 2014;85(2):168-73.

  5. Pérez A, Ramón C, Morís de la Tassa G, Pascual J. Marchiafava-Bignami disease triggered by poorly controlled diabetes mellitus. Neurol. 2016;31(7):498-500.

  6. Naaz A, Rizvi A, Amir M. Marchiafava-Bignami Disease Presenting as Acute Psychosis. Indian J Psychol Med. 2018;40(5):494-6.

  7. Kim R, Cho HJ, Lee HW, Jun JS. Refractory Nonconvulsive Status Epilepticus with Favorable Outcome in a Patient with Marchiafava-Bignami Disease. J Clin Neurol. 2019;15(3):393-4.

  8. Gopalkishna KP. Magnetic Resonance Imaging in Marchiafava-Bignami Syndrome: A Cornerstone in Diagnosis and Prognosis. Case Rep Radiol. 2014;60(97):8-15.

  9. Pansari N, Goyal R, Aswani P, Agrawal S, Verma H, Mahur H, et al. Marchiafava-Bignami Disease: A Rare Clinical Dilemma. J Assoc Physicians India. 2017;65(3):106-7.

  10. Dong X, Bai C, Nao J. Clinical and radiological features of Marchiafava-Bignami disease. Medicine (Baltimore). 2018;97(5):9626.




2020     |     www.medigraphic.com